Midkine (MDK), a heparin-binding growth factor, activates multiple key pathways such as MAPK, WNT, and TGF-β, leading to increased cancer proliferation, angiogenesis, and metastasis (Du et al. 2022; Sun et al. 2017). The gene discussed is TGFB1; the disease is cancer.